Literature DB >> 20384727

Deletions in 16p13 including GRIN2A in patients with intellectual disability, various dysmorphic features, and seizure disorders of the rolandic region.

Constanze Reutlinger1, Ingo Helbig, Barbara Gawelczyk, Jose Ignacio Martin Subero, Holger Tönnies, Hiltrud Muhle, Katrin Finsterwalder, Sascha Vermeer, Rolph Pfundt, Jürgen Sperner, Irina Stefanova, Gabriele Gillessen-Kaesbach, Sarah von Spiczak, Andreas van Baalen, Rainer Boor, Reiner Siebert, Ulrich Stephani, Almuth Caliebe.   

Abstract

Seizure disorders of the rolandic region comprise a spectrum of different epilepsy syndromes ranging from benign rolandic epilepsy to more severe seizure disorders including atypical benign partial epilepsy/pseudo-Lennox syndrome,electrical status epilepticus during sleep, and Landau-Kleffner syndrome. Centrotemporal spikes are the unifying electroencephalographic hallmark of these benign focal epilepsies, indicating a pathophysiologic relationship between the various epilepsies arising from the rolandic region. The etiology of these epilepsies is elusive, but a genetic component is assumed given the heritability of the characteristic electrographic trait. Herein we report on three patients with intellectual disability, various dysmorphic features, and epilepsies involving the rolandic region, carrying previously undescribed deletions in 16p13. The only gene located in the critical region shared by all three patients is GRIN2A coding for the alpha-2 subunit of the neuronal N-methyl-D-aspartate(NMDA) receptor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20384727     DOI: 10.1111/j.1528-1167.2010.02555.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  34 in total

1.  Sixteen New Cases Contributing to the Characterization of Patients with Distal 22q11.2 Microduplications.

Authors:  J Wincent; D L Bruno; B W M van Bon; A Bremer; H Stewart; E M H F Bongers; C W Ockeloen; M H Willemsen; D D A Keays; G Baird; D F Newbury; T Kleefstra; C Marcelis; U Kini; Z Stark; R Savarirayan; L J Sheffield; O Zuffardi; H R Slater; B B de Vries; S J L Knight; B-M Anderlid; J Schoumans
Journal:  Mol Syndromol       Date:  2011-05-18

2.  Glutamate receptors and learning and memory.

Authors:  Jozef Gécz
Journal:  Nat Genet       Date:  2010-11       Impact factor: 38.330

3.  Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes.

Authors:  Sabine Endele; Georg Rosenberger; Kirsten Geider; Bernt Popp; Ceyhun Tamer; Irina Stefanova; Mathieu Milh; Fanny Kortüm; Angela Fritsch; Friederike K Pientka; Yorck Hellenbroich; Vera M Kalscheuer; Jürgen Kohlhase; Ute Moog; Gudrun Rappold; Anita Rauch; Hans-Hilger Ropers; Sarah von Spiczak; Holger Tönnies; Nathalie Villeneuve; Laurent Villard; Bernhard Zabel; Martin Zenker; Bodo Laube; André Reis; Dagmar Wieczorek; Lionel Van Maldergem; Kerstin Kutsche
Journal:  Nat Genet       Date:  2010-10-03       Impact factor: 38.330

Review 4.  Mutations of N-Methyl-D-Aspartate Receptor Subunits in Epilepsy.

Authors:  Xing-Xing Xu; Jian-Hong Luo
Journal:  Neurosci Bull       Date:  2017-11-10       Impact factor: 5.203

Review 5.  New genes for focal epilepsies with speech and language disorders.

Authors:  Samantha J Turner; Angela T Morgan; Eliane Roulet Perez; Ingrid E Scheffer
Journal:  Curr Neurol Neurosci Rep       Date:  2015-06       Impact factor: 5.081

Review 6.  Genetic insights into the functional elements of language.

Authors:  Adam Szalontai; Katalin Csiszar
Journal:  Hum Genet       Date:  2013-06-08       Impact factor: 4.132

Review 7.  Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies.

Authors:  Julia Oyrer; Snezana Maljevic; Ingrid E Scheffer; Samuel F Berkovic; Steven Petrou; Christopher A Reid
Journal:  Pharmacol Rev       Date:  2018-01       Impact factor: 25.468

Review 8.  Epilepsy: old syndromes, new genes.

Authors:  Sarah Weckhuysen; Christian M Korff
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

9.  Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes.

Authors:  Johannes R Lemke; Dennis Lal; Eva M Reinthaler; Isabelle Steiner; Michael Nothnagel; Michael Alber; Kirsten Geider; Bodo Laube; Michael Schwake; Katrin Finsterwalder; Andre Franke; Markus Schilhabel; Johanna A Jähn; Hiltrud Muhle; Rainer Boor; Wim Van Paesschen; Roberto Caraballo; Natalio Fejerman; Sarah Weckhuysen; Peter De Jonghe; Jan Larsen; Rikke S Møller; Helle Hjalgrim; Laura Addis; Shan Tang; Elaine Hughes; Deb K Pal; Kadi Veri; Ulvi Vaher; Tiina Talvik; Petia Dimova; Rosa Guerrero López; José M Serratosa; Tarja Linnankivi; Anna-Elina Lehesjoki; Susanne Ruf; Markus Wolff; Sarah Buerki; Gabriele Wohlrab; Judith Kroell; Alexandre N Datta; Barbara Fiedler; Gerhard Kurlemann; Gerhard Kluger; Andreas Hahn; D Edda Haberlandt; Christina Kutzer; Jürgen Sperner; Felicitas Becker; Yvonne G Weber; Martha Feucht; Hannelore Steinböck; Birgit Neophythou; Gabriel M Ronen; Ursula Gruber-Sedlmayr; Julia Geldner; Robert J Harvey; Per Hoffmann; Stefan Herms; Janine Altmüller; Mohammad R Toliat; Holger Thiele; Peter Nürnberg; Christian Wilhelm; Ulrich Stephani; Ingo Helbig; Holger Lerche; Fritz Zimprich; Bernd A Neubauer; Saskia Biskup; Sarah von Spiczak
Journal:  Nat Genet       Date:  2013-08-11       Impact factor: 38.330

10.  GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction.

Authors:  Gaetan Lesca; Gabrielle Rudolf; Nadine Bruneau; Natalia Lozovaya; Audrey Labalme; Nadia Boutry-Kryza; Manal Salmi; Timur Tsintsadze; Laura Addis; Jacques Motte; Sukhvir Wright; Vera Tsintsadze; Anne Michel; Diane Doummar; Karine Lascelles; Lisa Strug; Patrick Waters; Julitta de Bellescize; Pascal Vrielynck; Anne de Saint Martin; Dorothee Ville; Philippe Ryvlin; Alexis Arzimanoglou; Edouard Hirsch; Angela Vincent; Deb Pal; Nail Burnashev; Damien Sanlaville; Pierre Szepetowski
Journal:  Nat Genet       Date:  2013-08-11       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.